GHRP-6
Growth Hormone Releasing Peptide-6, Growth hormone-releasing hexapeptide, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
Diet-induced obesity blunts the behavioural effects of ghrelin: studies in a mouse-progressive ratio task.
Finger. Beate C BC; Dinan. Timothy G TG; Cryan. John F JF
Key Findings
- Obese mice performed worse on tasks where they had to work harder for a sucrose reward.
- Giving ghrelin (or GHRP‑6) increased effort in lean mice but had no effect in obese mice.
- A ghrelin‑receptor antagonist reduced effort in lean mice but not in obese mice.
- Obese mice had lower ghrelin‑receptor mRNA levels in brain regions that control hunger and reward.
Practical Outcomes
- For biohackers using ghrelin‑related peptides to boost appetite, motivation, or reward‑driven performance, this study suggests the compounds may be far less effective in people with diet‑induced obesity. It highlights the importance of body composition when considering ghrelin agonists and may prompt users to focus on weight‑loss or metabolic health first before expecting performance benefits from GHRP‑6 or similar peptides.
Summary
In mice that become obese from a high‑fat diet, the hormone ghrelin (and drugs that mimic it, like GHRP‑6) no longer boost the drive to work for sweet rewards, and blocking the ghrelin receptor doesn’t reduce this drive either. This shows that obesity creates a resistance to ghrelin’s reward‑enhancing effects, not just its appetite‑stimulating effects.
Abstract
The ghrelinergic system is implicated in the development of obesity and in modulating central reward systems. It has been reported that diet-induced obesity causes blunted responding on food intake to ghrelin administration, associated with central ghrelin resistance. Here we investigate whether the stimulatory effects of ghrelin on the reward system are altered in diet-induced obese mice. Obesity was induced in C57BL/6J mice by feeding high-fat diet for 13 weeks. Mice were trained in an operant fixed and exponential progressive ratio task to respond for sucrose rewards. In an ad libitum fed state, ghrelin and a ghrelin receptor antagonist were administered in the progressive ratio. Alterations in the central ghrelin system in diet-induced obese mice were assessed. Obese mice showed attenuated acquisition and performance in the fixed and progressive ratio paradigm. Most importantly, diet-induced obesity inhibited the stimulatory effects of ghrelin (2 nmol, 3 nmol/10 g) on progressive ratio responding whereas lean animals presented with increased responding. Administration of the ghrelin-receptor antagonist (D-Lys(3))-GHRP-6 (66.6 nmol/10 g) decreased performance in lean but not obese mice. This insensitivity to ghrelin receptor ligands in mice on high-fat diet was further supported by decreased mRNA expression of the ghrelin receptor in the hypothalamus and the nucleus accumbens in obese mice. This study demonstrates that the modulatory effects of ghrelin receptor ligands are blunted in a mouse model of diet-induced obesity in a progressive ratio task. Thereby, our data extend the previously described ghrelin resistance in these mice from food intake to reward-associated behaviours.
Study Information
pubmed
2011
2011-09-03T00:00:00.000Z
10.1007/s00213-011-2468-0
56
59